P146 A Multicentre Retrospective Study Evaluating the Real-World Efficacy and Safety of Ritlecitinib in the Treatment of Alopecia Areata

    June 2026 in “ British Journal of Dermatology ”
    Grace Boyd, Hazel McMorrow, Art O’Hagan … Susannah Hoey
    Studysummary In this study, real-world data of 31 patients using ritlecitinib for severe alopecia areata showed that 51% achieved significant hair regrowth after one year, with no serious adverse events reported, emphasizing the importance of considering treatment duration for response.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →